Epigral Limited (formerly Meghmani Finechem Limited) has released its consolidated financial results for the quarter ended December 31, 2024, showcasing a solid performance with notable year-on-year (YoY) growth across key metrics.
Revenue Growth
The company reported a revenue from operations of ₹645.24 crore, reflecting a 36.8% YoY increase from ₹471.52 crore in the same quarter last year. Sequentially, revenue grew by 3.1% compared to ₹626.06 crore in the previous quarter.
Profitability Metrics
The net profit for the quarter stood at ₹103.63 crore, marking an impressive 111.3% YoY growth compared to ₹49.08 crore in Q3 FY24. On a quarter-on-quarter (QoQ) basis, net profit rose by 27.9% from ₹81.30 crore reported in the September 2024 quarter.
The company’s profit before tax (PBT) increased significantly to ₹153.62 crore, up 107.3% YoY from ₹73.93 crore in Q3 FY24.
Dividend Announcement
The company declared an interim dividend of ₹2.50 per equity share (25% of the face value of ₹10) for the financial year 2024-25. The record date for determining the eligibility of shareholders to receive the dividend has been fixed as Friday, February 7, 2025. The dividend will be credited or dispatched within 30 days of the declaration as per the provisions of the Companies Act, 2013.
Expense Analysis
Total expenses for the quarter were ₹495.57 crore, up 24% YoY from ₹399.82 crore in the corresponding period last year. However, the expenses decreased slightly on a sequential basis compared to ₹507.20 crore in the previous quarter.
Key Highlights
- EBITDA Margin: The company continued to show efficient cost management, boosting overall profitability.
- Power and Fuel Costs: These were reported at ₹30.78 crore, increasing slightly from ₹30.06 crore in the same period last year.
- Employee Benefits Expense: The expense rose to ₹29.09 crore, up 29.3% YoY from ₹22.50 crore in Q3 FY24.
Outlook
Epigral Limited’s consistent revenue growth and improved profitability reflect its operational efficiency and robust market demand. The company’s focus on cost management and strategic investments positions it well for sustained growth in the coming quarters.
Disclaimer: The above information is for informational purposes only and should not be considered investment advice. Always consult a financial advisor before making investment decisions.
